openPR Logo
Press release

Revcovi Market Report 2021: By Key Players, Application, Type, Share and Forecast 2021-2027

10-07-2021 07:26 AM CET | Health & Medicine

Press release from: Orion Market Research

The global revcovi (elapegademase-lvlr) market is estimated to grow at a significant CAGR during the forecast period. Revcovi generic name is Elapegademase-Lvlr. Adenosine deaminase severe combined immune deficiency the elapegademase-lVlr (ADA-SCID) is used to treat certain inherited immune system disorders. People with this disorder tend to have repeated and serious or life-threatening infections. Elapegademase-Lvlr is a human-made form in the human body of a substance (adenosine deaminase). It helps to increase the number and fight infection of blood cells (lymphocytes).

A full report of Revcovi Market is available at: https://www.omrglobal.com/industry-reports/revcovi-market

In October 2017, Leadiant Biosciences, Inc. announced that Revcovi (elapegademase-lvlr) injection has been approved by the Food and Drug Administration (FDA). Revcovi is a new enzyme substitute therapy (ERT) for treatment in paediatric patients and the case of adult patients of (ADA-SCID). Later, In October 2018, the FDA approved the drug priority review and Fast Track approval. Additionally, the FDA has designated the drug as an orphan drug.

ADA-SCID is a common genetic disorder that is caused by the mutation into the ADA gene that produces the Adenosine deaminase enzyme. It is also the cause of severe combined immunodeficiency (SCID) in children that affects about one out of every 200,000 newborns globally. Levels, resulting in the death of T- and B-cells. Revcovi (elapegademase-lvlr) drug provides an external source to the adenosine deaminase enzyme ADA enzyme breaks the plasma adenosine that causes accumulated intracellular adenosine to flow outward in the plasma cell.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/revcovi-market

The number of lymphocytes in the blood increases as a result of this. The Revcovi drug is available in a single dose that is a preservative-free sterile and colour free solution injected by the intramuscular route of administration. Revcovi assists the ADA enzyme in its function of removing leftover material from dividing cells. Thus the rising incidence of ADA-SCID is propelling the growth of the market.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segments Covered
o By Type
o By Application
• Regions Covered
o North America
o Europe
o Asia-Pacific
o Rest of the world
• Competitive Landscape- Leadiant Biosciences., Teijin Pharma Ltd.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Revcovi Market by Segments

By Type

• Pre-filled
• Vial

By Application

• Hospital
• Pharmacy

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/revcovi-market

Revcovi Market– Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Leadiant Biosciences.
• Teijin Pharma Ltd.

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Revcovi Market Report 2021: By Key Players, Application, Type, Share and Forecast 2021-2027 here

News-ID: 2420181 • Views:

More Releases from Orion Market Research

Veterinary Infectious Diseases Therapeutics Market Share and Competitive Dynamics: Zoetis, Merck, Boehringer Ingelheim, Elanco, Virbac
Veterinary Infectious Diseases Therapeutics Market Share and Competitive Dynamic …
Veterinary Infectious Diseases Therapeutics Market: The global veterinary therapeutics market was valued at USD 43.58 billion in 2023 and is projected to reach USD 82.40 billion by 2032, growing at a CAGR of 7.35% from 2024 to 2032. The market is highly competitive, with key players including Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, and Ceva Santé Animale. Companies are focusing on strategic acquisitions and partnerships to expand their product lines
Sodium-Dependent Glucose Co-Transporter2 (SDGL)2 Market Share and Competitive Dynamics: Eli Lilly, AstraZeneca, Johnson & Johnson, Merck, Boehringer Ingelheim
Sodium-Dependent Glucose Co-Transporter2 (SDGL)2 Market Share and Competitive Dy …
Sodium-Dependent Glucose Co-Transporter 2 (SGLT2) Market: The SGLT2 market size is estimated at USD 11.42 billion in 2024 and is expected to reach USD 17.32 billion by 2029, growing at a CAGR of 8.68% during the forecast period from 2024 to 2029. The Sodium-Dependent Glucose Co-Transporter 2 (SGLT2) market is experiencing significant growth due to the increasing prevalence of diabetes and chronic kidney disease (CKD). Rising awareness of SGLT2 inhibitors' benefits,
Photosensitizer Drug Market Share and Competitive Dynamics: Biolitec, Medlight, Steba Biotech, Theralase, Dusa Pharmaceuticals
Photosensitizer Drug Market Share and Competitive Dynamics: Biolitec, Medlight, …
Photosensitizer Drug Market: The photodynamic therapy market, which includes photosensitizer drugs, was valued at USD 2.4 billion in 2023 and is expected to reach USD 5.5 billion by 2033, growing at a CAGR of 8.3% from 2024 to 2033. The Photosensitizer Drug Market is experiencing steady growth due to increasing adoption in photodynamic therapy (PDT) for treating cancer, dermatological disorders, and ophthalmic conditions. Rising cancer prevalence, advancements in targeted drug delivery,
Phosphate Binders Market Share and Competitive Dynamics: Fresenius Kabi, Mylan, Amgen, Sanofi, Akorn
Phosphate Binders Market Share and Competitive Dynamics: Fresenius Kabi, Mylan, …
Phosphate Binders Market: In 2022, the global phosphate binders market was valued at approximately USD 4.74 billion and is projected to reach USD 6.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.09% from 2023 to 2030. The Phosphate Binders Market is experiencing steady growth, driven by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), where phosphate binders play a crucial role in

All 5 Releases


More Releases for Revcovi

2022 Revcovi Market Report- Current Trends, Size, Market Challenges and Key Play …
Along with market size, this research report covers the Revcovi Market across various segments. Revcovi Market offers in-depth market growth potential across different parts by services, class of devices, device types, and country. Revcovi Market research also incorporates competitive analysis of the key players along with their product launches, company profiles, key observation, Revcovi Market strategies, and recent developments Download FREE PDF of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5456854 Revcovi market is segmented by
Revcovi Market To Witness Huge Growth By 20267-Leadiant Biosciences , ,
The report on the global Revcovi market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including drivers, restraints, and opportunities. It sheds light on key production, revenue, and consumption trends so that players could improve their sales and growth in the Global Revcovi Market. It offers a detailed analysis of the competition and leading companies of the global Revcovi market. Here, it
Revcovi Market Growth 2020-2025: Leadiant Biosciences and other players
Revcovi Industry Description Wiseguyreports.Com Adds “Revcovi -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database Revcovi is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. In 2017, the global Revcovi market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to
Elapegademase-lvlr Market Analysis - Industry Trends, Market Size, and Forecast …
In the last several years, global market of Elapegademase-lvlr developed rapidly, with an average growth rate of 9.14% during 2014 to 2018. In 2018, global revenue of Elapegademase-lvlr is nearly 11 M USD; the actual sales are about 1934 Unit. Revcovi (elapegademase-lvlr) is a new enzyme replacement therapy indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. View Full Report : https://reports.valuates.com/sreport/QYRE-Auto-16Q312/Global_Elapegademase_lvlr_Market This report focuses
Revcovi Market Overview Future and Forecast 2025, Global key developing manufact …
An up-to-date research report has been disclosed by Market Research Hub highlighting the title “Global Revcovi Market Size, Demand, Application, Overview Future and Forecast 2025” which provides an outlook for current market value as well as the expected growth of "Revcovi Market" during 2018-2025. The report studies the casing heads market worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, size, growth, revenue, consumption, import
Global Adenosine Deaminase Deficiency Therapeutic Market Research Report 2018-20 …
The global market status for Adenosine Deaminase Deficiency Therapeutic is precisely examined through a smart research report added to the broad database managed by Market Research Hub (MRH). This study is titled “Global Adenosine Deaminase Deficiency Therapeutic Market” Insights, Forecast to 2025, which tends to deliver in-depth knowledge associated to the Adenosine Deaminase Deficiency Therapeutic market for the present and forecasted period until 2025. Furthermore, the report examines the target